Suicide gene therapy of sarcoma cell lines using recombinant adeno-associated virus 2 vectors

Cancer Gene Therapy

Volumn 11, Issue 8, 2004, Pages 577-584

  Veldwij, Marlon R ^a,b   Berlinghoff, Simone ^b   Laufs, Stephanie ^b   Hengge, Ulrich R ^c   Zeller, W Jens ^b   Wenz, Frederik ^a   Fruehauf, Stefan ^d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adeno associated virus 2; Ganciclovir; NOD SCID mice; Sarcoma; Suicide gene therapy; Thymidine kinase

Indexed keywords

ELONGATION FACTOR 1; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; THYMIDINE KINASE; THYMIDINE KINASE ENHANCED GREEN FLUORESCENT FUSION PROTEIN; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS 2; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASKIN TUMOR; CELL SURVIVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG SENSITIVITY; EWING SARCOMA; FIBROSARCOMA; FUSION GENE; GENE CONTROL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RHABDOMYOSARCOMA; SARCOMA CELL; SCID MOUSE; SOFT TISSUE SARCOMA; SUICIDE GENE THERAPY; TRANSGENE; VIRUS GENE; VIRUS RECOMBINANT; XENOTRANSPLANTATION;

ANIMALS; CELL LINE, TUMOR; CYTOMEGALOVIRUS; DEPENDOVIRUS; GANCICLOVIR; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; PEPTIDE ELONGATION FACTOR 1; PROMOTER REGIONS (GENETICS); SARCOMA; THYMIDINE KINASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ANIMALIA; CYTOMEGALOVIRUS; PARVOVIRUS;

EID: 4043179681     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700718     Document Type: Article

References (39)

1. Brennan MF, Casper ES, Harrison LB. Soft-tissue sarcoma. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer, Principles and Practice of Oncology. Ed. 5. Philadelphia, PA: Lippincott-Raven; 1997: 1738-1788.
2. Verweij J, Lee SM, Ruka W, et al. Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic Soft-tissue sarcomas in adults: a study of the european organization for research and treatment of cancer Soft-tissue and bone sarcoma group. J Clin Oncol. 2000;18:2081-2086.
3. Hasenburg A, Tong XW, Fischer DC, et al. Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up. Gynecol Oncol. 2001;83:549-554.
4. Sung MW, Yeh HC, Thung SN, et al. Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial. Mol Ther. 2001;4:182-191.
5. Kanazawa T, Urabe M, Mizukami H, et al. Gamma-rays enhance rAAV-mediated transgene expression and cytocidal effect of AAV-HSVtk/ganciclovir on cancer cells. Cancer Gene Ther. 2001;8:99-106.
6. Nguyen JB, Sanchez-Pernaute R, Cunningham J, Bankiewicz KS. Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport. 2001;12:1961-1964.
7. Kruse CA, Lamb C, Hogan S, et al. Purified herpes simplex thymidine kinase retroviral particles II. Influence of clinical parameters and bystander killing mechanisms. Cancer Gene Ther. 2000;7:118-127.
8. Carrio M, Mazo A, Lopez-Iglesias C, Estivill X, Fillat C. Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: implications for gene therapy. Int J Cancer. 2001;94:81-88.
9. Cheng YC, Huang ES, Lin JC, et al. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci USA. 1983;80:2767-2770.
10. Okada T, Shah M, Higginbotham JN, et al. AV/TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor deposits. Gene Therapy. 2001;8: 1315-1322.
11. Bantel-Schaal U. Adeno-associated parvoviruses inhibit growth of cells derived from malignant human tumors. Int J Cancer. 1990;45:190-194.
12. Klein-Bauernschmitt P, von Knebel-Doeberitz M, Ehrbar M, et al. Improved efficacy of chemotherapy by parvovirus-mediated sensitisation of human tumour cells. Eur J Cancer. 1996;32a:1774-1780.
13. Rosenfeld MR, Bergman I, Schramm L, et al. Adenoassociated viral vector gene transfer into leptomeningeal xenografts. J Neurooncol. 1997;34:139-144.
14. Maass G, Bogedain C, Scheer U, et al. Recombinant adenoassociated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction efficiency into primary epithelial cancer cells. Hum Gene Ther. 1998;9:1049-1059.
15. Veldwijk MR, Schiedlmeier B, Kleinschmidt JA, et al. Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocks. Eur J Cancer. 1999;35:1136-1142.
16. Veldwijk MR, Fruehauf S, Schiedlmeier B, et al. Differential expression of a recombinant adeno-associated virus 2 vector in human CD34 + cells and breast cancer cells. Cancer Gene Ther. 2000;7:597-604.
17. Fillat C, Carrio M, Cascante A, Sangro B. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. Curr Gene Ther. 2003;3:13-26.
18. Grimm D, Kern A, Rittner K, Kleinschmidt JA. Novel tools for production and purification of recombinant AAV vectors. Hum Gene Ther. 1998;9:2745-2760.
19. Zolotukhin S, Potter M, Hauswirth WW, et al. "Humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol. 1996;70: 4646-4654.
20. Salmon P, Kindler V, Ducrey O, et al. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood. 2000;96:3392-3398.
21. Steffens S, Frank S, Fischer U, et al. Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapy. Cancer Gene Ther. 2000;7:806-812.
22. Veldwijk MR, Topaly J, Laufs S, et al. Rapid determination of adeno-associated virus 2 vector titers using an optimized real-time quantitative polymerase chain reaction-based titration assay that meets clinical laboratory standards. Mol Ther. 2002;6:272-278.
23. Salvetti A, Oreve S, Chadeuf G, et al. Factors influencing recombinant adeno-associated virus production. Hum Gene Ther. 1998;9:695-706.
24. Giard DJ, Aaronson SA, Todaro GJ, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51:1417-1423.
25. Reeves BR, Fisher C, Smith S, et al. Ultrastructural, immunocytochemical, and cytogenetic characterization of a human epithelioid sarcoma cell line (RM-HS1). J Natl Cancer Inst. 1987;78:7-18.
26. Rasheed S, Nelson-Rees WA, Toth EM, et al. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer. 1974;33:1027-1033.
27. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973;33:2643-2652.
28. Dunn T, Praissman L, Hagag N, Viola MV. ERG gene is translocated in an Ewing's sarcoma cell line. Cancer Genet Cytogenet. 1994;76:19-22.
29. Tamayose K, Hirai Y, Shimada T. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum Gene Ther. 1996;7:507-513.
30. Auricchio A, Hildinger M, O'Connor E, et al. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther. 2001;12:71-76.
31. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
32. Beltinger C, Fulda S, Kammertoens T, et al. Mitochondrial amplification of death signals determines thymidine kinase/ ganciclovir-triggered activation of apoptosis. Cancer Res. 2000;60:3212-3217.
33. Koshikawa N, Takenaga K, Tagawa M, Sakiyama S. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells. Cancer Res. 2000;60:2936-2941.
34. Miyauchi M, Yoshida Y, Tada Y, et al. Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells. Int J Cancer. 2001;91:723-727.
35. Rivas C, Miller AR, Collado M, et al. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir. Mol Ther. 2001;3: 642-652.
36. Prochazka M, Gaskins HR, Shultz LD, Leiter EH. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA. 1992;89:3290-3294.
37. Kasper B, Fruehauf S, Schiedlmeier B, et al. Xenograft models for normal and malignant human hematopoiesis - possibilities for new treatment strategies. In: Fiebig HH, Burger AM, (Eds.): Relevance of tumor models for anticancer drug development. Basel, Karger, Contrib Oncol. 1999;54:233-248.
38. Schiedlmeier B, Kuhlcke K, Eckert HG, et al. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice, Blood. 2000;95: 1237-1248.
39. Laufs S, Gentner B, Nagy KZ, et al. Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood. 2003;101: 2191-2198.